Key facts
- Notable investors include Sunshine Ronghui Capital Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Hubei Gedian Humanwell Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hubei Gedian Humanwell Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hubei Gedian Humanwell Pharmaceutical
Manufacturer of fertility regulation drugs and steroidal APIs intended to serve the pharmaceutical industry. The company has two API manufacturing sites, one formulation factory, and one excipient factory, with a diverse portfolio of products including Steroidal, Central Nervous System (CNS), and antiviral drugs.
- Sector
- Healthcare
- HQ
- Tianmen, China
- Founded
- 2013
- Website
- steroid-chem.com/
- Ownership
- Privately Held (backing)
Hubei Gedian Humanwell Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hubei Gedian Humanwell Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hubei Gedian Humanwell Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.